Rockwell Medical (RMTI) to Release Earnings on Monday

Rockwell Medical (NASDAQ:RMTIGet Rating) is set to post its quarterly earnings results after the market closes on Monday, May 16th. Analysts expect Rockwell Medical to post earnings of ($0.09) per share for the quarter. Individual that are interested in participating in the company’s earnings conference call can do so using this link.

Shares of Rockwell Medical stock opened at $2.02 on Friday. The firm has a market capitalization of $189.85 million, a PE ratio of -5.94 and a beta of 1.09. The company has a debt-to-equity ratio of 5.21, a current ratio of 1.68 and a quick ratio of 1.49. The company’s fifty day moving average price is $0.40 and its two-hundred day moving average price is $0.41. Rockwell Medical has a 52-week low of $1.92 and a 52-week high of $11.66.

A hedge fund recently raised its stake in Rockwell Medical stock. Renaissance Technologies LLC lifted its position in Rockwell Medical, Inc. (NASDAQ:RMTIGet Rating) by 81.1% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 225,534 shares of the company’s stock after purchasing an additional 101,000 shares during the quarter. Renaissance Technologies LLC owned 0.24% of Rockwell Medical worth $92,000 at the end of the most recent reporting period. Institutional investors own 27.88% of the company’s stock.

Several equities research analysts have issued reports on the stock. StockNews.com assumed coverage on shares of Rockwell Medical in a report on Friday. They issued a “hold” rating on the stock. Zacks Investment Research raised shares of Rockwell Medical from a “sell” rating to a “hold” rating in a report on Thursday, March 17th. Finally, HC Wainwright lowered their target price on shares of Rockwell Medical from $5.00 to $3.00 and set a “buy” rating on the stock in a report on Tuesday, January 18th.

About Rockwell Medical (Get Rating)

Rockwell Medical, Inc operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iron therapy that replaces iron and maintains hemoglobin in dialysis patients without increasing iron stores.

Featured Articles

Earnings History for Rockwell Medical (NASDAQ:RMTI)

Receive News & Ratings for Rockwell Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rockwell Medical and related companies with MarketBeat.com's FREE daily email newsletter.